platinum has been researched along with alovudine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aboagye, EO; Gabra, H; Perumal, M; Stronach, EA | 1 |
Ball, DL; Chabrot, M; Everitt, SJ; Hicks, RJ; Leimgruber, A; MacManus, M; Möller, A; Solomon, B | 1 |
1 trial(s) available for platinum and alovudine
Article | Year |
---|---|
Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Non-Small-Cell Lung; Cell Count; Cell Proliferation; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neutrophils; Organ Specificity; Platinum; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed | 2014 |
1 other study(ies) available for platinum and alovudine
Article | Year |
---|---|
Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Chlorpropamide; Dideoxynucleosides; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mice; Ovarian Neoplasms; Platinum; Positron-Emission Tomography; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |